Market Overview

Brainstorm Cell Therapeutics Shares Spike On Volume, Boston Globe Publishes: 'Trials for potential ALS treatment spark cautious hope' Wherein CEO Lebovits Says of NurOwn Treatment: 'We have seen wonderful results in a smaller patient population'

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Biotech FDA Media Trading Ideas General

 

Related Articles (BCLI)

Benzinga's Top Analyst Calls From April 5, 2018

Amazon Could Win The Cloud Wars With Automation, Says KeyBanc Analyst